Shire — FDA Facility Profile

FEI 3001237683

Shire is an FDA-inspected facility (FEI 3001237683) located in Chesterbrook, PA, US. RegDataLab tracks 3 FDA inspections at this facility.

Reviewing Shire as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Shire yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Dec 2, 2010: Voluntary Action Indicated (VAI)
Inspections on record
3 (2 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
1, latest Sep 2, 2016
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 2, 2010Voluntary Action Indicated (VAI)No citations listed
Apr 22, 2010Voluntary Action Indicated (VAI)Equipment Design, Size and Location (21 CFR 211.63)
Investigations of discrepancies, failures (21 CFR 211.192)
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Contamination, chemical or physical change, deterioration (21 CFR 314.81(b)(1)(ii))
Aug 5, 2009No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 2, 2016Class IIID-0006-2017Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only…
Presence of Foreign Tablets/Capsules

Facility details

Company
Shire
Location
Chesterbrook, PA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.